Form DEFA14A Walgreens Boots Alliance

Go back to Form DEFA14A Walgreens Boots Alliance

Raymond James Reiterates Market Perform Rating on Walgreens Boosts Alliance (WBA)

March 7, 2025 1:05 PM EST

Raymond James analyst John Ransom reiterated a Market Perform rating on Walgreens Boosts Alliance (NASDAQ: WBA).

The analyst comments "Last night WBA announced they have agreed to a deal to be taken private by Sycamore Partners (private equity) for $11.45/share + a potential $3/share upside from a divested asset proceeds right (DAP) that is contingent on the company selling VillageMD, Summit Health, and CityMD post close of the deal. The deal implies a ~$10B equity value for the remainco (drugstore, Shields, Boots), but a total enterprise value up to $23.7B including liabilities (debt and... More

Walgreens Boosts Alliance (WBA) PT Raised to $11.45 at Jefferies

March 7, 2025 10:38 AM EST

Jefferies analyst Brian Tanquilut raised the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $11.45 (from $11.00) while maintaining a Hold rating.

The analyst comments "We think WBA's decision to go private for $11.45/share in cash (which values the company... More